Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B₆C₃F₁ mice

References

• Andersen, M. E., Butenhoff, J. L., Chang, S. C., Farrar, D. G., Kennedy, G. L. Jr Lau, C., Olsen, G.W., Seed, J. and Wallace, K. B. 2008. Perfluoroalkyl acids and related chemistries–toxicokinetics and modes of action. Toxicol. Sci. 102:3–14.
   PubMed Web of Science ®Google Scholar
• Ankley, G. T., Kuehl, D. W., Kahl M. D., Jensen, K. M., Linnum, A., Leino, R. L. and Villeneuvet, D. A. 2005. Reproductive and developmental toxicity and bioconcentration of perfluorooctanesulfonate in a partial life-cycle test with the fathead minnow (Pimephales promelas). Environ Toxicol Chem., 24(9):2316–2324.
   Google Scholar
• Austin, M. E., Kasturi, B. S., Barber, M., Kannan, K., MohanKumar, P. S. and MohanKumar, S. M. 2003. Neuroendocrine effects of perfluorooctane sulfonate in rats. Environ. Health Perspect. 111:1485–1489.
   PubMed Web of Science ®Google Scholar
• Baccam, M. and Bishop, G. A. 1999. Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B-cells. Eur. J. Immunol. 29:3855–3866.
   PubMedGoogle Scholar
• Baccam, M., Woo, S. Y., Vinson, C. and Bishop, G. A. 2003. CD40-mediated transcriptional regulation of the IL-6 gene in B-lymphocytes: Involvement of NF-kappa B, AP-1, and C/EBP. J. Immunol. 170:3099–3108.
   PubMed Web of Science ®Google Scholar
• Bauer, J. 1991. IL-6 in clinical medicine. Ann. Hematol. 62:203–210.
   PubMed Web of Science ®Google Scholar
• Bishop, G. A. and Hostager, B. S. 2003. The CD40–CD154 interaction in B-cell-T-cell liaisons. Cytokine Growth Factor Rev. 14:297–309.
   PubMedGoogle Scholar
• Boss, B. and Neeck, G. 2000. Correlation of IL-6 with the classical humoral disease activity parameters ESR and CRP and with serum cortisol, reflecting the activity of the HPA axis in active rheumatoid arthritis. Z. Rheumatol. 59(Suppl. 2):II/62–II/64.
   Google Scholar
• Burleson, G. R. and Burleson, F. G. 2008. Testing human biologicals in animal host resistance models. J. Immunotoxicol. 52:3–31.
   Google Scholar
• Calafat, A. M., Kuklenyik, Z., Reidy, J. A., Caudill, S. P., Tully, J. S. and Needham, L. L. 2007a. Serum concentrations of 11 polyfluoroalkyl compounds in the U.S. population: Data from the National Health and Nutrition Examination Survey (NHANES). Environ. Sci. Technol. 41:2237–2242.
   PubMed Web of Science ®Google Scholar
• Calafat, A. M., Wong, L. Y., Kuklenyik, Z., Reidy, J. A. and Needham, L. L. 2007b. Polyfluoroalkyl chemicals in the U.S. population: Data from the National Health and Nutrition Examination Survey (NHANES) 2003–2004 and comparisons with NHANES 1999–2000. Environ. Health Perspect. 115:1596–1602.
   PubMed Web of Science ®Google Scholar
• Case, M. T., York, R. G. and Christian, M. S. 2001. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. Int. J. Toxicol. 20:101–109.
   PubMed Web of Science ®Google Scholar
• Chang, S. C., Thibodeaux, J. R., Eastvold, M. L., Ehresman, D. J., Bjork, J. A., Froehlich, J. W., Lau, C., Singh, R. J., Wallace, K. B. and Butenhoff, J. L. 2008. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS). Toxicology 243:330–339.
   PubMed Web of Science ®Google Scholar
• Contin, C., Pitard, V., Delmas, Y., Pelletier, N., Defrance, T., Moreau, J. F., Merville, P. and Dé,chanet-Merville, J. 2003. Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients. Immunology 110:131–140.
   PubMed Web of Science ®Google Scholar
• Cunard, R., DiCampli, D., Archer, D. C., Stevenson, J. L., Ricote, M., Glass, C. K. and Kelly, C. J. 2002a. WY14,643, a PPAR alpha ligand, has profound effects on immune responses in vivo. J. Immunol. 169:6806–6812.
   PubMed Web of Science ®Google Scholar
• Cunard, R., Ricote, M., DiCampli, D., Archer, D. C., Kahn, D. A., Glass, C. K. and Kelly, C. J. 2002b. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J. Immunol. 168:2795–2802.
   PubMed Web of Science ®Google Scholar
• Delerive, P., De Bosscher, K., Besnard, S., Vanden Berghe, W., Peters, J. M., Gonzalez, F. J., Fruchart, J. C., Tedgui, A., Haegeman, G. and Staels, B. 1999. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J. Biol. Chem. 274:32048–32054.
   PubMed Web of Science ®Google Scholar
• DeWitt, J. C., Copeland, C. B. and Luebke, R. W. 2009a. Suppression of humoral immunity by perfluorooctanoic acid is independent of elevated serum corticosterone concentration in mice. Toxicol. Sci. 109:106–112.
   PubMed Web of Science ®Google Scholar
• DeWitt, J. C., Copeland, C. B., Strynar, M. J. and Luebke, R. W. 2008. Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice. Environ. Health Perspect. 116:644–650.
   PubMed Web of Science ®Google Scholar
• DeWitt, J. C., Shnyra, A., Badr, M. Z., Loveless, S. E., Hoban, D., Frame, S. R., Cunard, R., Anderson, S. E., Meade, B. J., Peden-Adams, M. M., Luebke, R. W. and Luster, M. I. 2009b. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit. Rev. Toxicol. 39:76–94.
   PubMed Web of Science ®Google Scholar
• Dickerson, R., Keller, L. H. and Safe, S. 1995. Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: Structure–activity studies. Toxicol. Appl. Pharmacol. 135:287–298.
   PubMed Web of Science ®Google Scholar
• Dong, G. H., Zhang, Y. H., Zheng, L., Liu, W., Jin, Y. H. and He, Q. C. 2009. Chronic effects of perfluorooctanesulfonate exposure on immunotoxicity in adult male C57BL/6 mice. Arch. Toxicol. 83:805–815.
   PubMed Web of Science ®Google Scholar
• Evans, J. S., Varney, R. F. and Koch, F. C. 1941. The mouse uterine wet weight method for the assay of estrogens. Endocrinology 28:747–752.
   Google Scholar
• Fang, X., Feng, Y., Shi, Z. and Dai, J. 2009. Alterations of cytokines and MAPK signaling pathways are related to the immunotoxic effect of perfluorononanoic acid. Toxicol. Sci. 108:367–376.
   Google Scholar
• Fang, X., Zhang, L., Feng, Y., Zhao, Y. and Dai, J. 2008. Immunotoxic effects of perfluorononanoic acid on BALB/c mice. Toxicol. Sci. 105:312–321.
   PubMed Web of Science ®Google Scholar
• Faustman, E. M. and Omenn, G. S. 2001. Risk assessment. In: Casarett and Doull’s Toxicology: The Basic Science of Poisons (Klaassen, C. D., Ed), New York: McGraw-Hill Companies, Inc, pp. 83–104.
   Google Scholar
• Fort, D., Rodgers, R. L., Guiney, P. D. and Weeks, J. A. 2007. Effects of Perfluorooctane Sulfonate (PFOS) Exposure on Steroidogensis in Juvenile Xenopus (Silurana) tropicalis. Society of Environmental Toxicology and Chemistry—Abstract Book, 28th Annual Meeting, November 11–15, Milwaukee, WI, pp. 231.
   Google Scholar
• Fuentes, S., Colomina, M. T., Rodriguez, J., Vicens, P. and Domingo, J. L. 2006. Interactions in developmental toxicology: Concurrent exposure to perfluorooctane sulfonate (PFOS) and stress in pregnant mice. Toxicol. Lett. 164:81–89.
   PubMed Web of Science ®Google Scholar
• Fuentes, S., Colomina, M. T., Vicens, P., Franco-Pons, N. and Domingo, J. L. 2007. Concurrent exposure to perfluorooctane sulfonate and restraint stress during pregnancy in mice: Effects on postnatal development and behavior of the offspring. Toxicol. Sci. 98:589–598.
   Google Scholar
• Giesy, J. P. and Kannan, K. 2001. Global distribution of perfluorooctane sulfonate in wildlife. Environ. Sci. Technol. 35:1339–1342.
   PubMed Web of Science ®Google Scholar
• Grasty, R. C., Wolf, D. C., Grey, B. E., Lau, C. S. and Rogers, J. M. 2003. Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res. B Dev. Reprod. Toxicol. 68:465–471.
   PubMed Web of Science ®Google Scholar
• Grewal, I. S. and Flavell, R. A. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. 16:111–135.
   PubMed Web of Science ®Google Scholar
• Gupta, M. K., Chiang, T. and Deodhar, S. D. 1983. Effect of thyroxine on immune response in C57Bl/6J mice. Acta Endocrinol. 103:76–80.
   PubMedGoogle Scholar
• Guruge, K. S., Hikono, H., Shimada, N., Murakami, K., Hasegawa, J., Yeung, L. W., Yamanaka, N. and Yamashita, N. 2009. Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice. J. Toxicol. Sci. 34:687–691.
   PubMed Web of Science ®Google Scholar
• Houde, M., Wells, R. S., Fair, P. A., Bossart, G. D., Hohn, A. A., Rowles, T. K., Sweeney, J. C., Solomon, K. R. and Muir, D. C. 2005. Polyfluoroalkyl compounds in free-ranging bottlenose dolphins (Tursiops truncatus) from the Gulf of Mexico and the Atlantic Ocean. Environ. Sci. Technol. 39:6591–6598.
   PubMed Web of Science ®Google Scholar
• Jaattela, M. 1991. Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. Lab. Invest. 64(6), 724–742.
   Google Scholar
• Jin, Y., Saito, N., Harada, K. H., Inoue, K. and Koizumi, A. 2007. Historical trends in human serum levels of perfluorooctanoate and perfluorooctane sulfonate in Shenyang, China. Tohoku J. Exp. Med. 212:63–70.
   PubMed Web of Science ®Google Scholar
• Johnson, J. D., Gibson, S. J. and Ober, R. E. 1984. Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of ammonium [14C]perfluorooctanoate or potassium [14C]-perfluorooctanesulfonate. Fundam. Appl. Toxicol. 4:972–976.
   PubMedGoogle Scholar
• Kanda N., Tsuchida T. and Tamaki K. 1996. Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin Exp Immunol., 106(2):410–415.
   Google Scholar
• Kanda N. and Tamaki K. 1999. Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol. 103(2 Pt 1):282–288.
   Google Scholar
• Kannan, K., Franson, J. C., Bowerman, W. W., Hansen, K. J., Jones, P. D. and Giesy, J. P. 2001. Perfluorooctane sulfonate in fish-eating water birds including bald eagles and albatrosses. Environ. Sci. Technol. 35:3065–3070.
   PubMed Web of Science ®Google Scholar
• Kannan, K., Perrotta, E. and Thomas, N. J. 2006. Association between perfluorinated compounds and pathological conditions in southern sea otters. Environ. Sci. Technol. 40:4943–4948.
   PubMed Web of Science ®Google Scholar
• Kanno, J., Onyon, L., Haseman, J., Fenner-Crisp, P., Ashby, J. and Owens, W. Organisation for Economic Co-operation and Development. 2001. The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. Environ. Health Perspect. 109:785–794.
   PubMed Web of Science ®Google Scholar
• Keil, D. E., McGuinn, W. D., Dudley, A. C., EuDaly, J. G., Gilkeson, G. S. and Peden-Adams, M. M. 2009. N, N,-Diethyl-m-toluamide (DEET) suppresses humoral immunological function in B6C3F1 mice. Toxicol. Sci. 108:110–123.
   PubMedGoogle Scholar
• Keil, D. E., Mehlmann, T., Butterworth, L. and Peden-Adams, M. M. 2008. Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. Toxicol. Sci. 103:77–85.
   PubMed Web of Science ®Google Scholar
• Keller, J. M., Kannan, K., Taniyasu, S., Yamashita, N., Day, R. D., Arendt, M. D., Segars, A. L. and Kucklick, J. R. 2005. Perfluorinated compounds in the plasma of loggerhead and Kemp’s ridley sea turtles from the southeastern coast of the United States. Environ. Sci. Technol. 39:9101–9108.
   PubMed Web of Science ®Google Scholar
• Kissa, E. (Ed.). 2001. Fluorinated Surfactants and Repellents, 2nd Ed., New York: Marcel Keller.
   Google Scholar
• Klaus, G. G., Holman, M., Johnson-Léger, C., Christenson, J. R. and Kehry, M. R. 1999. Interaction of B-cells with activated T-cells reduces the threshold for CD40-mediated B-cell activation. Int. Immunol. 11:71–79.
   Google Scholar
• Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A. and Seed, J. 2007. Perfluoroalkyl acids: A review of monitoring and toxicological findings. Toxicol. Sci. 99:366–394.
   PubMed Web of Science ®Google Scholar
• Lau, C., Thibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Stanton, M. E., Butenhoff, J. L. and Stevenson, L. A. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Post-natal evaluation. Toxicol. Sci. 74:382–392.
   PubMed Web of Science ®Google Scholar
• Lee, B. O., Moyron-Quiroz, J., Rangel-Moreno, J., Kusser, K. L., Hartson, L., Sprague, F., Lund, F. E. and Randall, T. D. 2003. CD40, but not CD154, expression on B-cells is necessary for optimal primary B-cell responses. J. Immunol. 171:5707–5717.
   PubMed Web of Science ®Google Scholar
• Lefebvre, D. E., Curran, I., Armstrong, C., Coady, L., Parenteau, M., Liston, V., Barker, M., Aziz, S., Rutherford, K., Bellon-Gagnon, P., Shenton, J., Mehta, R. and Bondy, G. 2008. Immunomodulatory effects of dietary potassium perfluorooctane sulfonate (PFOS) exposure in adult Sprague-Dawley rats. J. Toxicol. Environ. Health Part A 71:1516–1525.
   PubMed Web of Science ®Google Scholar
• Lehmler, H. J. 2005. Synthesis of environmentally relevant fluorinated surfactants—a review. Chemosphere 58:1471–1496.
   PubMed Web of Science ®Google Scholar
• Li, Y. Y., Baccam, M., Waters, S. B., Pessin, J. E., Bishop, G. A. and Koretzky, G. A. 1996. CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B-cells. J. Immunol. 157:1440–1447.
   PubMed Web of Science ®Google Scholar
• Liu, J., Na, S., Glasebrook, A., Fox, N., Solenberg, P. J., Zhang, Q., Song, H. Y. and Yang, D. D. 2001. Enhanced CD4+ T-cell proliferation and TH2 cytokine production in DR6-deficient mice. Immunity 15:23–34.
   PubMedGoogle Scholar
• Loveless, S. E., Hoban, D., Sykes, G., Frame, S. R. and Everds, N. E. 2008. Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate. Toxicol. Sci. 105:86–96.
   PubMed Web of Science ®Google Scholar
• Luebker, D. J., Hansen, K. J., Bass, N. M., Butenhoff, J. L. and Seacat, A. M. 2002. Interactions of fluorochemicals with rat liver fatty acid-binding protein. Toxicology 176:175–185.
   PubMed Web of Science ®Google Scholar
• Luster, M. I., Munson, A. E., Thomas, P. T., Holsapple, M. P., Fenters, J. D., White, K. L. Jr, Lauer, L. D., Germolec, D. R., Rosenthal, G. J. and Dean, J. H. 1988. Development of a testing battery to assess chemical-induced immunotoxicity: National Toxicology Program’s guidelines for immunotoxicity evaluation in mice. Fundam. Appl. Toxicol. 10:2–19.
   PubMedGoogle Scholar
• Luster, M. I., Portier, C., Pait, D. G., Rosenthal, G. J., Germolec, D. R., Corsini, E., Blaylock, B. L., Pollock, P., Kouchi, Y. and Craig, W. 1993. Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam. Appl. Toxicol. 21:71–82.
   PubMedGoogle Scholar
• Luster, M. I., Portier, C., Pait, D. G., White, K. L. Jr Gennings, C., Munson, A. E., and Rosenthal, G. J. 1992. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam. Appl. Toxicol. 18:200–210.
   PubMedGoogle Scholar
• Mollenhauer, M. A. 2008. Determination of the Role of PPARα in Inflammatory Processes Following Perfluorooctane Sulfonate Exposure in a Murine Model. Dissertation, Medical University of South Carolina.
   Google Scholar
• Moody, C. A. and Field, J. A. 2000. Perfluorinated surfactants and the environmental implications of their use in fire-fighting foams. Environ. Sci. Technol. 34:3864–3870.
   Web of Science ®Google Scholar
• Nandakumar, D. N., Koner, B. C., Vinayagamoorthi, R., Nanda, N., Negi, V. S., Goswami, K., Bobby, Z. and Hamide, A. 2008. Activation of NF-kappaB in lymphocytes and increase in serum immunoglobulin in hyperthyroidism: Possible role of oxidative stress. Immunobiology 213:409–415.
   PubMed Web of Science ®Google Scholar
• Nelson, D. L. Jr, Frazier, D. E. Ericson, J. E., Tarr, M. J. and Mathes, L. E. 1992. The effects of perfluorodecanoic acid (PFDA) on humoral, cellular, and innate immunity in Fischer 344 rats. Immunopharmacol. Immunotoxicol. 14:925–938.
   PubMed Web of Science ®Google Scholar
• Noe, S. N., Newton, C., Widen, R., Friedman, H. and Klein, T. W. 2000. Anti-CD40, anti-CD3, and IL-2 stimulation induce contrasting changes in CB1 mRNA expression in mouse splenocytes. J. Neuroimmunol. 110:161–167.
   Google Scholar
• OECD. 2002. Hazard Assessment of Perfluorooctane Sulfonate (PFOS) and its Salts. ENV/JM/RD(2002)17/Final. http://www.oecd.org/document/58/0,2340,en_2649_34379_2384378_1_1_1_1,00.html. Accessed May 12, 2004
   Google Scholar
• Okazaki, K., Imazawa, T., Nakamura, H., Furukawa, F., Nishikawa, A. and Hirose, M. 2002. A repeated 28-day oral dose toxicity study of 17alpha-methyltestosterone in rats, based on the ‘enhanced OECD Test Guideline 407’ for screening the endocrine-disrupting chemicals. Arch. Toxicol. 75:635–642.
   PubMed Web of Science ®Google Scholar
• Olsen, G. W., Burris, J. M., Burlew, M. M. and Mandel, J. H. 2003a. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J. Occup. Environ. Med. 45:260–270.
   PubMed Web of Science ®Google Scholar
• Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L. and Zobel, L. R. 2007. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ. Health Perspect. 115:1298–1305.
   PubMed Web of Science ®Google Scholar
• Olsen, G. W., Church, T. R., Miller, J. P., Burris, J. M., Hansen, K. J., Lundberg, J. K., Armitage, J. B., Herron, R. M., Medhdizadehkashi, Z., Nobiletti, J. B., O’Neill, E. M., Mandel, J. H. and Zobel, L. R. 2003b. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ. Health Perspect. 111:1892–1901.
   PubMed Web of Science ®Google Scholar
• Olsen, G. W., Huang, H. Y., Helzlsouer, K. J., Hansen, K. J., Butenhoff, J. L. and Mandel, J. H. 2005. Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood. Environ. Health Perspect. 113:539–545.
   PubMed Web of Science ®Google Scholar
• Olsen, G. W., Mair, D. C., Church, T. R., Ellefson, M. E., Reagen, W. K., Boyd, T. M., Herron, R. M., Medhdizadehkashi, Z., Nobiletti, J. B., Rios, J. A., Butenhoff, J. L. and Zobel, L. R. 2008. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000–2006. Environ. Sci. Technol. 42:4989–4995.
   PubMed Web of Science ®Google Scholar
• Owens, J. W. and Ashby, J. 2002. Critical review and evaluation of the uterotrophic bioassay for the identification of possible estrogen agonists and antagonists: In support of the validation of the OECD uterotrophic protocols for the laboratory rodent. Organisation for Economic Co-operation and Development. Crit. Rev. Toxicol. 32:445–520.
   PubMed Web of Science ®Google Scholar
• Peden-Adams, M. M., EuDaly, J. G., Dabra, S., EuDaly, A., Heesemann, L., Smythe, J. and Keil, D. E. 2007. Suppression of humoral immunity following exposure to the perfluorinated insecticide sulfluramid. J. Toxicol. Environ. Health Part A. 70:1130–1141.
   PubMed Web of Science ®Google Scholar
• Peden-Adams, M. M., Keil, D. E., Romano, T., Mollenhauer, M. A. M., Fort, D. J., Guiney, P. D., Houde, M., Kannan, K., Muir, D. C., Rice, C. D., Stuckey, J., Segars, A. L., Scott, T., Talent, L., Bossart, G. D., Fair, P. A. and Keller, J. M. 2009a. Health effects of perfluorinated compounds—what are the wildlife telling us? Reprod. Toxicol. 27:414–415.
   Google Scholar
• Peden-Adams, M. M., Keller, J. M., Eudaly, J. G., Berger, J., Gilkeson, G. S. and Keil, D. E. 2008. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol. Sci. 104:144–154.
   PubMed Web of Science ®Google Scholar
• Peden-Adams, M. M., Stuckey, J. E., Gaworecki, K. M., Berger-Ritchie, J., Bryant, K., Jodice, P. G., Scott, T. R., Ferrario, J. B., Guan, B., Vigo, C., Boone, J. S., McGuinn, W. D., DeWitt, J. C. and Keil, D. E. 2009b. Developmental toxicity in white leghorn chickens following in ovo exposure to perfluorooctane sulfonate (PFOS). Reprod. Toxicol. 27:307–318.
   PubMed Web of Science ®Google Scholar
• Pérez-Melgosa, M., Hollenbaugh, D. and Wilson, C. B. 1999. Cutting edge: CD40 ligand is a limiting factor in the humoral response to T-cell-dependent antigens. J. Immunol. 163:1123–1127.
   Google Scholar
• Qazi, M. R., Bogdanska, J., Butenhoff, J. L., Nelson, B. D., DePierre, J. W. and Abedi-Valugerdi, M. 2009a. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. Toxicology 262:207–214.
   PubMed Web of Science ®Google Scholar
• Qazi, M. R., Xia, Z., Bogdanska, J., Chang, S. C., Ehresman, D. J., Butenhoff, J. L., Nelson, B. D., DePierre, J. W. and Abedi-Valugerdi, M. 2009b. The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha). Toxicology 260:68–76.
   PubMed Web of Science ®Google Scholar
• Reimers, T. J., Cowan, R. G., Davidson, H. P. and Colby, E. D. 1981. Validation of radioimmunoassay for triiodothyronine, thyroxine, and hydrocortisone (cortisol) in canine, feline, and equine sera. Am. J. Vet. Res. 42:2016–2021.
   PubMed Web of Science ®Google Scholar
• Renwick, A. G. 1995. Toxicokinetics. In: General and Applied Toxicology: College Edition (Ballantyne, B., Marrs, T., Turner, P., Eds.), New York: Stockton Press, pp. 111–142.
   Google Scholar
• Schonbeck, U. and Libby, P. 2001. The CD40/CD154 receptor/ligand dyad. Cell. Mol. Life Sci. 58:4–43.
   PubMed Web of Science ®Google Scholar
• Seacat, A. M., Thomford, P. J., Hansen, K. J., Clemen, L. A., Eldridge, S. R., Elcombe, C. R. and Butenhoff, J. L. 2003. Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology 183:117–131.
   PubMed Web of Science ®Google Scholar
• Seacat, A. M., Thomford, P. J., Hansen, K. J., Olsen, G. W., Case, M. T. and Butenhoff, J. L. 2002. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicol. Sci. 68:249–264.
   PubMed Web of Science ®Google Scholar
• Selgrade, M. K. 2007. Immunotoxicity: The risk is real. Toxicol. Sci. 100:328–332.
   PubMed Web of Science ®Google Scholar
• Selgrade, M. K. 1999. Use of immunotoxicity data in health risk assessments: Uncertainties and research to improve the process. Toxicology 133:59–72.
   PubMed Web of Science ®Google Scholar
• Shipley, J. M., Hurst, C. H., Tanaka, S. S., DeRoos, F. L., Butenhoff, J. L., Seacat, A. M. and Waxman, D. J. 2004. Trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals. Toxicol. Sci. 80:151–160.
   PubMed Web of Science ®Google Scholar
• Son, H. Y., Lee, S., Tak, E. N., Cho, H. S., Shin, H. I., Kim, S. H. and Yang, J. H. 2009. Perfluorooctanoic acid alters T-lymphocyte phenotypes and cytokine expression in mice. Environ. Toxicol. 24:580–588.
   PubMed Web of Science ®Google Scholar
• Szocinski, J. L., Khaled, A. R., Hixon, J., Halverson, D., Funakoshi, S., Fanslow, W. C., Boyd, A., Taub, D. D., Durum, S. K., Siegall, C. B., Longo, D. L. and Murphy, W. J. 2002. Activation-induced cell death of aggressive histology lymphomas by CD40 stimulation: Induction of bax. Blood 100:217–223.
   PubMed Web of Science ®Google Scholar
• Tedder, T. F., Inaoki, M. and Sato, S. 1997. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6:107–118.
   PubMed Web of Science ®Google Scholar
• Thibodeaux, J. R., Hanson, R. G., Rogers, J. M., Grey, B. E., Barbee, B. D., Richards, J. H., Butenhoff, J. L., Stevenson, L. A. and Lau, C. 2003. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations. Toxicol. Sci. 74:369–381.
   PubMed Web of Science ®Google Scholar
• Ullrich, S. E. 1999. Dermal application of JP-8 jet fuel induces immune suppression. Toxicol Sci., 52(1):61–67.
   Google Scholar
• Wetzel, L. T. 1983. Rat Teratology Study, T-3351, Final Report. Hazelton Laboratories America, Inc. Project number 154–160. December 19, 1983 (8EHQ-0399-374). Available on USEPA Public docket AR-226 (No. 226-0014).
   Google Scholar
• Xu, Y. and Song, G. 2004. The role of CD40–CD154 interaction in cell immunoregulation. J. Biomed. Sci. 11:426–438.
   Google Scholar
• Yang, Q., Abedi-Valugerdi, M., Xie, Y., Zhao, X. Y., Möller, G., Nelson, B. D. and DePierre, J. W. 2002b. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int. Immunopharmacol. 2:389–397.
   PubMed Web of Science ®Google Scholar
• Yang, Q., Xie, Y., Alexson, S. E., Nelson, B. D. and DePierre, J. W. 2002a. Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. Biochem. Pharmacol. 63:1893–1900.
   PubMed Web of Science ®Google Scholar
• Yang, Q., Xie, Y. and Depierre, J. W. 2000. Effects of peroxisome proliferators on the thymus and spleen of mice. Clin. Exp. Immunol. 122:219–226.
   PubMed Web of Science ®Google Scholar
• Yang, Q., Xie, Y., Eriksson, A. M., Nelson, B. D. and DePierre, J. W. 2001. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. Biochem. Pharmacol. 62:1133–1140.
   PubMed Web of Science ®Google Scholar
• Zheng, L., Dong, G. H., Jin, Y. H. and He, Q. C. 2009. Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL/6 mice. Arch. Toxicol. 83:679–689.
   PubMed Web of Science ®Google Scholar